Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yifei Cheng
Comments on the Article: ‘Donor-Derived CD19-targeted T Cell Infusion Induces Minimal Residual Disease-Negative Remission in Relapsed B-Cell Acute Lymphoblastic Leukaemia With No Response to Donor Lymphocyte Infusions After Haploidentical Haematopoietic S
British Journal of Haematology
Hematology
Related publications
Comments on the Article ‘Donor-Derived CD19-targeted T Cell Infusion Induces Minimal Residual Disease-Negative Remission in Relapsed B-Cell Acute Lymphoblastic Leukaemia With No Response to Donor Lymphocyte Infusions After Haploidentical Haematopoietic St
British Journal of Haematology
Hematology
Molecular Remission Induced by Gemtuzumab Ozogamicin Associated With Donor Lymphocyte Infusions in T(4;11) Acute Lymphoblastic Leukemia Relapsed After Transplantation
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Persistent Multiyear Control of Relapsed T-Cell Acute Lymphoblastic Leukemia With Successive Donor Lymphocyte Infusions: A Case Report
Pediatric Blood and Cancer
Oncology
Child Health
Hematology
Perinatology
Medicine
Pediatrics
Concurrent Use of Blinatumomab and Donor Lymphocyte Infusion (DLI) for Treatment of Relapsed Precursor B Cell Acute Lymphoblastic Leukemia (Pre B ALL) After Allogeneic Hematopoietic Cell Transplant (HCT)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Long-Term Survival Following Post-Allograft Relapse of T-Cell Acute Lymphoblastic Leukaemia: A Novel Approach Using Nelarabine and Donor Lymphocyte Infusions
Bone Marrow Transplantation
Transplantation
Hematology
Donor Derived T-Cell Large Granular Lymphocyte Leukemia After Cord Blood Transplant for Pediatric T-Cell Lymphoblastic Leukemia
Bone Marrow Transplantation
Transplantation
Hematology
Donor Lymphocyte Infusion Induced Molecular Remission in Relapse of Acute Myeloid Leukaemia After Allogeneic Bone Marrow Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
FDA Approval: Blinatumomab for Patients With B-Cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission With Minimal Residual Disease
Clinical Cancer Research
Cancer Research
Oncology
Clinical Utility of Next-Generation Sequencing-Based Minimal Residual Disease in Paediatric B-Cell Acute Lymphoblastic Leukaemia
British Journal of Haematology
Hematology
